Agenda
The following agenda is for the 2026 Indy Hematology Review event.
Saturday, March 7th, 2026
| Time | Event/Topic |
|---|---|
| 6:00 AM - 10:00 AM | Registration |
| 6:45 AM - 7:25 AM | Breakfast Product Theaters |
Precursory Events
Session 1
| Time | Event/Topic |
|---|---|
| 7:30 AM–8:00 AM | State of the Art 2026: Emerging Therapies in Hematologic Malignancies Ruemu E. Birhiray, MD Professor of Medicine Marian University - Wood College of Osteopathic Medicine |
| 8:00 AM- 8:20 AM | Updating our Armamentarium: Emerging Treatment Options for Newly Diagnosed Patients with AML and Myelodysplastic Syndromes Rami Komrokji, MD Vice chair of the Malignant Hematology Department Moffitt Cancer Center |
| 8:20 AM- 8:40 AM | Approaches to the Application of therapeutic Advances to the relapsed Patient with AML and Myelodysplastic Syndromes TBD TBD TBD |
| 8:40 AM - 9:00 AM | Choosing Wisely: Prognostication and Optimal Therapies for Myeloproliferative Neoplasms Ayalew Tefferi, MD Barbara Woodward Lips II Professor of Medicine Mayo Clinic |
| 9:00 AM - 9:20 AM | Choosing Wisely: Management of Chronic Myeloid Leukemia in 2026 Richard Larson, MD Director of Hematologic Malignancies Clinical Research Program University of Chicago Cancer Center |
| 9:20 AM - 9:30 AM | Myeloid Leukemias - Panel Discussion |
| 9:30 AM- 9:45 AM | Coffee Break - Exhibit Hall |
| 9:45 AM - 10:05 AM | Emerging Therapeutic Approaches to the Management of Newly Diagnosed Multiple Myeloma Kenneth Anderson, MD Kraft Family Professor of Medicine Harvard Medical School |
| 10:05 AM-10:25 AM | Emerging Therapeutic Approaches to the Management of Newly Diagnosed Multiple Myeloma Saad Usmani, MD, MBA, FACP, FRCP Chief of Myeloma Service Memorial Sloan Kettering Cancer Center |
| 10:25 AM -10:45 AM | Why You Should Not Treat Smoldering Multiple Myeloma Outside a Clinical Trial and Current management of Amyloidosis Morie Gertz, MD, MACP Chair Emeritus Department of Medicine Mayo Clinic |
| 10:45 AM-11:05 AM | Advancing Care: Treating Waldenstrom’s Macroglobulinemia in Today’s Patients Steven P. Treon, MD, MA, PhD, FRCP, FACP Professor of Medicine Harvard Medical School |
| 11:05 AM-11:15 AM | Plasma Cell and Lymphoplasmacytic Neoplasms - Panel Discussion |
| 11:15 AM- 11:25 AM | Coffee Break - Exhibit Hall |
| 11:25 AM-11:45 AM | Advancing Options and Treatment Paradigms for Aplastic Anemia and Complementopathies Robert Brodsky, MD Johns Hopkins Family Professor of Medicine and Oncology Johns Hopkins University School of Medicine |
| 11:45 AM - 12:05 PM | VEXAS and Somatic Mutation ‘Benign’ Diseases Neal Young, MD Bethesda, Maryland |
| 12:05 PM-12:25 PM | Modern Approaches to Classical Hematology: Navigating Bleeding and Clotting Disorders Craig Kessler, MD, MACP Professor of Medicine and Pathology Georgetown University Medical Center |
| 12:25 PM - 12:45 PM | Treatment Options and Cellular Therapy for Sickle Cell Disease TBD TBD TBD |
| 12:45 PM-12:55 PM | Hematology - Panel Discussion |
| 1:05 PM - 1:50 PM | Lunch and Product Theaters |
| 1:50 PM - 2:00 PM | Coffee Break - Exhibit Hall |
Session Chair: Ruemu E. Birhiray, MD
Session 2
Session Chair: Michael Wiemann, MD, FACP
| Time | Event/Topic |
|---|---|
| 2:00 PM- 2:45 PM | T. Howard Lee Keynote Lecture Beyond the Great Pond: A Global Approach to Managing the Controversies in the Treatment of Mantle Cell Lymphomas Martin Dreyling, MD Professor of Medicine Ludwig Maximilian University of Munich |
| 2:45 PM-3:05 PM | Acute Lymphoblastic Leukemia: Navigating Current and Emerging Treatment Strategies Richard Stone, MD, IO Lunder Family Chair in Leukemia and Chief of Staff Dana-Farber Cancer Institute |
| 3:05 PM- 3:25 PM | Current and Emerging Treatment Options of Blastic Plasmacytoid Dendritic Cell Neoplasm and Myeloid/Lymphoid Neoplasms with eosinophilia and Tyrosine Kinase (TK) gene fusions Naveen Pemmaraju, MD Associate Professor in the Department of Leukemia MD Anderson Cancer Center |
| 3:25 PM- 3:30 PM | Lymphoid Neoplasms - Panel Discussion |
| 3:30 PM- 3:50 PM | APPLYING EMERGING DATA in My Current Strategies for Managing Relapsed Chronic Lymphocytic Leukemia Jennifer Woyach, MD Professor in the College of Medicine The Ohio State University School of Medicine |
| 3:50 PM - 4:10 PM | Annual Steven Coutré Chronic Lymphocytic Leukemia Memorial Lecture Approaching the Newly Diagnosed Patient with CLL in 2026 TBD TBD TBD |
| 4:10 PM - 4:20 PM | Coffee Break - Exhibit Hall |
| 4:20 PM - 4:40 PM | Emerging Strategies in the Treatment of Indolent Lymphoma Gilles Salles, MD, PhD Chief of Lymphoma Service and Steven A. Greenberg Chair Memorial Sloan Kettering Cancer Center |
| 4:40 PM - 5:00 PM | “Primum non nocere” Applying Emerging Strategies for the Treatment of Hodgkin Lymphoma Stephen Ansell, MD, PhD Professor of Medicine Mayo Clinic |
| 5:00 PM - 5:35 PM | Cutting-Edge Advances in Treating Aggressive B and T Cell Lymphomas Sonali Smith, MD, FASCO Elwood V. Jensen Professorship of Medicine UChicagoMedicine |
| 5:35 PM -5:55 PM | T-cell Redirected Antibody Therapy for Lymphoid Malignancies Tycel Phillips, MD Associate Professor of Medicine City of Hope |
| 5:55 PM - 6:15 PM | Revolutionizing Lymphoid Malignancies with Cellular Therapy Matthew Lunning, DO, FACP Professor of Medicine University of Nebraska Medical Center |
| 6:15 PM - 6: 35 PM | Harnessing Immune Effector Therapies in Multiple Myeloma Joselle Cook, MD Assistant Professor of Medicine Mayo Clinic |
| 6:35 PM - 6:55 PM | Hematopoietic Transplantation and Cellular Therapies: When to Refer Richard Childs Bethesda, Maryland |
| 6:55 PM - 7:10 PM | Lymphoid Malignancies and Cellular Therapies - Panel Discussion |
| 7:10 PM - 7:30 PM | Hors D'oeuvres |
| 7:30 PM - 8:30 PM | Hematologic Malignancies Townhall |
| Ruemu E. Birhiray, MD – Chair and Moderator | |
| Michael Wiemann, MD, FACP – Co-Chair | |
| Morie Gertz, MD, MACP – Plasma Cell Disorders and Amyloidosis | |
| Jennifer Woyach, MD – Chronic Lymphocytic Leukemia | |
| Rami Komrokji, MD – Acute Leukemias and Myelodysplastic Syndromes | |
| TBD – Lymphomas | |
| Saad Usmani, MD, MBA – Multiple Myeloma | |
| Joselle Cook, MD – Multiple Myeloma | |
| Naveen Pemmaraju, MD – Myeloproliferative Neoplasms |